BioSpace News Archive

Drug Development

First Patient Screened in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis

Mallinckrodt plc today confirmed screening of the first patient in the company’s Phase 4, multi-center, multiple-dose, open label study to assess the effects of H.P. Acthar Gel as a therapy option in patients with Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis (NIPPU).

October 26, 2018
·
11 min read
Business

Zimmer Biomet Announces Third Quarter 2018 Financial Results

Net sales of $1.837 billion for the third quarter represent an increase of 1.3% over the prior year period, and an increase of 2.3% on a constant currency basis

October 26, 2018
·
36 min read
Pharm Country

Regeneron Ranked #1 Biopharma Employer for Sixth Time by Science Magazine

Company Also Celebrates Second Annual Global Day of Service.

October 26, 2018
·
4 min read
Genetown

Immunomic Therapeutics Senior Director of Corporate Development to Present at Precision Lung Cancer World R&D Summit

Discussion of lysosomal targeting technology as applied in cancer immunotherapy

October 26, 2018
·
4 min read
Pharm Country

The Galien Foundation Announces 2018 #PrixGalien Award Recipients

Work spans gender equity to advances in non-Hodgkin lymphoma; leukemia; and atrial fibrillation

October 26, 2018
·
2 min read
Aachen-based Startup Company Protembis Successfully Closes $ 10 Million Series A Financing

The Managing Directors and founders of Protembis GmbH, Karl von Mangoldt and Conrad Rasmus, have successfully closed a Series A financing round in a structured process.

October 26, 2018
·
4 min read
Policy

Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio

Mayne Pharma Group Limited (“Mayne Pharma”) (ASX: MYX) has acquired the FDA approved halobetasol propionate foam 0.05% for an investment of up to US$32 million and an ongoing earn out payment

October 26, 2018
·
7 min read
Advicenne Wins Prestigious Prix Galien - Medstartup Award for Best Innovative Trial Design Leading to Quicker and Better Therapeutic Outcomes

Award recognizes ADV7103 in development for the treatment of distal Renal Tubular Acidosis (dRTA)

October 26, 2018
·
5 min read
Drug Development

Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development

Proceeds to fund Phase 2/3 trial of inhaled TD139 in idiopathic pulmonary fibrosis (IPF) and advancement of oral and ocular pipeline candidates into clinical studies

October 26, 2018
·
4 min read
Drug Development

Presentation at ASN Kidney Week 2018 Highlights Stable Renal Function at up to 24 Months Following Transplantation Enabled by Imlifidase

Hansa Medical AB today announced that data on imlifidase was highlighted in a presentation at the American Society of Nephrology (ASN) Kidney Week 2018.

October 26, 2018
·
4 min read